NPR News: Novavax Vaccine Effective, But Doesn't Work As Well Against South African Variant

Novavax Vaccine Effective, But Doesn't Work As Well Against South African Variant
There's another COVID-19 vaccine. This one was developed by the U.S. biotech company Novavax. It's almost 90% effective against the disease, but isn't as effective against the South African variant

Read more on NPR